289 | MULTICENTER REAL‐WORLD OUTCOMES OF FRONTLINE POLA‐R‐CHP IN TREATMENT NAÏVE DLBCL

作者：S. K. Thiruvengadam, Liangyi Chen, Sophie Buller, Venkatesh Iyengar, Gloria Isabel Carvajal Peláez, V. Pizzuti, Arkady Major, Youssef Youssef, Yazeed Sawalha, D. Wallace, M. Masterson, Nicole Birrer, Allison M. Bock, Adrienne Nedved, Y. Wang, Thomas Lucido, James B. Rhodes, Jennifer L. Crombie, Denisse Montana, Michele Stanchina, Juan Pablo Alderuccio, Alyssa Gibson, Peter A. Riedell, Tushar Jain, Birgitta Heyman, Heather Rasmussen, Chaitra S. Ujjani, Perry M. Gould, Hua‐Jay J. Cherng, A. Bahnasy, Talal Hilal, Bernard F. Parker, Muhamad Alhaj Moustafa, Sok Cheon Pak, Michelle Okwali, Jessica Chicola, José María Manzano, Christine Goth, David A. Russler‐Germain, Pallawi Torka, Alex F. Herrera · 发表于：Hematological Oncology · 年份：2025 · DOI：10.1002/hon.70094_289 · 被引用次数：3 · 研究领域：Advanced Breast Cancer Therapies、Genomic variations and chromosomal abnormalities